Spago Nanomedical AB
SPAGO | ST
Overview
Corporate Details
- ISIN(s):
- SE0004899474 (+2 more)
- LEI:
- 549300DNLTVJ4OGO5X40
- Country:
- Sweden
- Address:
- Scheelevägen 22, 223 63 Lund
- Website:
- https://spagonanomedical.se/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Spago Nanomedical is a clinical-stage nanomedicine company developing products for improved diagnostics and treatment of life-threatening diseases. The company leverages a proprietary platform of polymeric materials to create precision medical solutions. Its development pipeline is led by two key projects: SpagoPix and Tumorad®. SpagoPix (candidate drug SN132D) is a contrast agent designed to enhance the precision of MRI in detecting tumors and abnormalities in organs like the breast, liver, and pancreas. Tumorad® (candidate drug SN201) is a targeted radionuclide therapy being developed for the treatment of various cancers, which has shown favorable tumor accumulation in preclinical studies. The company's focus is on improving patient outcomes through more precise and effective diagnostics and therapies.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Spago Nanomedical AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Spago Nanomedical AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Spago Nanomedical AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
